Plasma fibrinogen in NIDDM the Rotterdam study

Diabetes Care

Volumn 19, Issue 2, 1996, Pages 157-159

  Missov, Rossen M ^a   Stolk, Ronald P ^a   Van Der Bom, Johanna G ^a   Hofman, Albert ^a   Bots, Michiel L ^a   Pols, Huibert A P ^a   Grobbee, Diederick E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CREATININE; FIBRINOGEN; FRUCTOSAMINE; INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION;

AGE FACTORS; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOGEN; FRUCTOSAMINE; HEXOSAMINES; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NETHERLANDS; REFERENCE VALUES; SEX CHARACTERISTICS; SEX FACTORS; SMOKING;

EID: 0030045819     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.2.157     Document Type: Article

References (15)

1. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993
2. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501-515, 1984
3. Cook NS, Ubben D: Fibrinogen as a major risk factor in cardiovascular disease. Trend Pharmacol Sci 11:444-451, 1990
4. Donahue RP, Orchard TJ: Diabetes mellitus and macrovascular complications: an epidemiological perspective. Diabetes Care 15:1141-1155, 1992
5. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685, 1993
6. Ganda OP, Arkin CF: Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250, 1992
7. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR: Diabetes fibrinogen and risk of cardiovascular disease: the Framingham experience Am Heart J 120:672-676, 1990
8. Mittelmark MB, Psaty BM, Rautaharju PM, Fried LP, Borham NO, Tracy RP, Gardin JM, O'Leary DH: Prevalence of cardiovascular diseases among older adults: the Cardiovascular Health Study. Am J Epidemiol 137.311-317, 1993
9. Hofman A, Grobbee DE, De Jong PT, Van Den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7.403-422, 1991
10. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. Geneva, World Health Org., 1982
11. Rossi E, Mondonico P, Lombardi A, Preda L: Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 52:453-468, 1988
12. Knobl P, Schemihaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, Muller M: Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050, 1993
13. Shihabi ZK, Konen JC, McCormick CP: Plasma fibrinogen levels in type II diabetics. Clin Physiol Biochem 8:297-300, 1990
14. Tahara Y, Shima K: Kinetics of HbA(1c), glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18:440-447, 1995
15. Vanninen E, Laitinen J, Uusitupa M: Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care 17-1031-1038, 1994